Amundi’s Shockwave Medical, Inc. Common Stock SWAV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-311,780
Closed -$102M 2072
2024
Q1
$102M Sell
311,780
-129,074
-29% -$31.7M 0.04% 372
2023
Q4
$89.5M Buy
440,854
+319,524
+263% +$60.4M 0.04% 407
2023
Q3
$23.4M Buy
121,330
+55,678
+85% +$13.2M 0.01% 670
2023
Q2
$18.3M Buy
65,652
+6,080
+10% +$1.69M 0.01% 707
2023
Q1
$13.8M Buy
59,572
+2,053
+4% +$400K 0.01% 773
2022
Q4
$11.5M Sell
57,519
-2,405
-4% -$608K 0.01% 829
2022
Q3
$17.1M Sell
59,924
-8,182
-12% -$2.08M 0.01% 730
2022
Q2
$13.6M Buy
68,106
+18,713
+38% +$3.3M 0.01% 707
2022
Q1
$10.6M Buy
49,393
+48,365
+4,705% +$7.97M 0.01% 800
2021
Q4
$189K Buy
+1,028
New +$203K ﹤0.01% 1487

Other funds holding SWAV

Amundi's SWAV Position: Q2 2024 in Review

Amundi sold out of Shockwave Medical, Inc. Common Stock (SWAV) in Q2 2024, closing a stake of 311,780 shares — an estimated $102M sold.

Amundi first reported a position in SWAV in Q4 2021 and held it in 10 quarters. The position peaked at $102M in Q1 2024. 7 funds tracked by Wall St. Rank hold SWAV as of Q2 2024.

  • Amundi reported no remaining Shockwave Medical, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • Amundi sold 311,780 Shockwave Medical, Inc. Common Stock shares in Q2 2024, an estimated $102M.
  • Amundi first reported a position in Shockwave Medical, Inc. Common Stock in Q4 2021 and held it in 10 quarters.
  • Amundi's Shockwave Medical, Inc. Common Stock position peaked at $102M in Q1 2024.
  • 7 funds tracked by Wall St. Rank held Shockwave Medical, Inc. Common Stock as of Q2 2024.

Based on Amundi's 13F filing for Q2 2024, filed 14 Aug 2024.